Stock HAE HAEMONETICS CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Haemonetics Corporation

Equities

HAE

US4050241003

Delayed Nyse
Other stock markets
 20:54:08 06/05/2024 BST 		5-day change 1st Jan Change
95.33 USD +0.99% Intraday chart for Haemonetics Corporation +4.25% +11.55%
04-04 Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge MT
04-04 Haemonetics Corporation Receives FDA Clearance for New TEG®? 6s Global Hemostasis - HN Cartridge CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
PR
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
AQ
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
PR
Haemonetics Corporation Completes Acquisition of Attune Medical
PR
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
PR
Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference
PR
Haemonetics to Present at Citi's 2024 Unplugged Medtech and Life Sciences Access Day
PR
Haemonetics: Fiscal Q3 Earnings Snapshot
AQ
Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2024 Results: February 8, 2024
PR
Haemonetics Corporation Completes Acquisition of OpSens Inc.
PR
Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
OPSENS RECEIVES INTERIM ORDER AND FILES MANAGEMENT INFORMATION CIRCULAR IN CONNECTION WITH SPECIAL MEETING OF SHAREHOLDERS
AQ
Haemonetics: Fiscal Q2 Earnings Snapshot
AQ
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PR
Haemonetics : to Acquire OpSens, Inc. Presentation
PU
OPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY HAEMONETICS
AQ
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2024 Results: November 2, 2023
PR
Haemonetics Announces European Expansion for VASCADE® Vascular Closure System
PR
Haemonetics: Fiscal Q1 Earnings Snapshot
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HAE Stock
  4. News Haemonetics Corporation
  5. Press Releases